March 30, 2015 | Israeli pharmaceutical giant Teva Pharmaceutical Industries has agreed to acquire Auspex Pharmaceuticals for $3.5 billion. The acquisition will strengthen Teva’s portfolio of treatments for the central nervous system. Teva was originally founded in 1901 as Salomon, Levin, and Elstein.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
UK Adopts Israeli Counter-Drone Technology
April 25, 2024
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments